PORTAL HYPERTENSION
Clinical trials for PORTAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PORTAL HYPERTENSION trials appear
Sign up with your email to follow new studies for PORTAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug may ease liver pressure in hepatitis d patients
Disease control OngoingThis study looks at whether the drug Bulevirtide can reduce high blood pressure in the liver (portal hypertension) in people with hepatitis B and D who also have liver cirrhosis. High liver pressure can lead to serious problems, and this treatment aims to control it by suppressin…
Matched conditions: PORTAL HYPERTENSION
Sponsor: Hannover Medical School • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Hidden costs of liver disease: new study tracks financial toll on patients and families
Knowledge-focused OngoingThis study looks at how social and financial challenges—like income, education, and out-of-pocket costs—affect people with cirrhosis and their caregivers. Researchers will ask participants and their caregivers about financial stress and healthcare use. The goal is to better under…
Matched conditions: PORTAL HYPERTENSION
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated May 17, 2026 05:35 UTC